Bypass Surgery and CD133 Marrow Cell Injection for Treatment of Ischemic Heart Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Coronary Artery Disease With Need for Bypass SurgeryMyocardial Ischemia, Angina PectorisCongestive Heart FailurePrevious Myocardial Infarction
Interventions
PROCEDURE

Intramyocardial injection of autologous CD133+ marrow cells

Trial Locations (1)

13353

Deutsches Herzzentrum Berlin, Berlin

Sponsors
All Listed Sponsors
collaborator

Miltenyi Biomedicine GmbH

INDUSTRY

lead

German Heart Institute

OTHER